Monte Rosa Therapeutics, Inc. Common Stock (GLUE) Stock Price, Quote & AI Analysis

Live GLUE stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Monte Rosa Therapeutics, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Monte Rosa Therapeutics, Inc. Common Stock (GLUE), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

GLUE
Monte Rosa Therapeutics, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
15.870000
High
16.265000
Low
15.770000
Volume
780,868
VWAP
-
Market Cap
$1,344,539,199.76
52W Range
$4.30 - $25.77
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Nov 4, 2026 Q3
Market
EPS Estimate: $-0.4021
Revenue Estimate: $5,634,143.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Monte Rosa Therapeutics, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Monte Rosa Therapeutics, Inc. Common Stock Overview

Company information

Company Overview

Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Company Details
Market Cap
$1.39B
Shares Outstanding
87,421,275
Weighted Shares Outstanding
85,313,401
CEO
Markus Warmuth
Address
321 HARRISON AVENUE, BOSTON, MA, 02118
Employees
173
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Monte Rosa Therapeutics, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...